Southern Asia: Medicaments Containing Hormones Market 2024

Medicaments Containing Hormones Market Size in Southern Asia

The South Asian medicaments containing hormones market totaled $X in 2022, approximately equating the previous year. In general, consumption continues to indicate a remarkable increase. The level of consumption peaked at $X in 2020; afterwards, it flattened through to 2022.

Medicaments Containing Hormones Production in Southern Asia

In value terms, medicaments containing hormones production stood at $X in 2022 estimated in export price. Overall, production continues to indicate a remarkable increase. The pace of growth appeared the most rapid in 2015 when the production volume increased by X%. The level of production peaked at $X in 2020; afterwards, it flattened through to 2022.

Medicaments Containing Hormones Exports

Exports in Southern Asia

In 2022, shipments abroad of medicaments containing hormones but not antibiotics increased by X% to X tons, rising for the fourth consecutive year after six years of decline. In general, exports, however, faced a abrupt decline. The volume of export peaked at X tons in 2012; however, from 2013 to 2022, the exports remained at a lower figure.

In value terms, medicaments containing hormones exports rose sharply to $X in 2022. Overall, exports, however, showed a drastic downturn. The most prominent rate of growth was recorded in 2016 when exports increased by X%. Over the period under review, the exports attained the peak figure at $X in 2013; however, from 2014 to 2022, the exports stood at a somewhat lower figure.

Exports by Country

Pakistan prevails in exports structure, resulting at X tons, which was approx. X% of total exports in 2022. India (X tons) followed a long way behind the leaders.

Pakistan was also the fastest-growing in terms of the medicaments containing hormones but not antibiotics exports, with a CAGR of X% from 2012 to 2022. India (X%) illustrated a downward trend over the same period. From 2012 to 2022, the share of Pakistan increased by X percentage points.

In value terms, Pakistan ($X) remains the largest medicaments containing hormones supplier in Southern Asia, comprising X% of total exports. The second position in the ranking was held by India ($X), with a X% share of total exports.

In Pakistan, medicaments containing hormones exports plunged by an average annual rate of X% over the period from 2012-2022.

Export Prices by Country

The export price in Southern Asia stood at $X per ton in 2022, which is down by X% against the previous year. Overall, the export price showed a abrupt setback. The pace of growth was the most pronounced in 2013 when the export price increased by X% against the previous year. The level of export peaked at $X per ton in 2017; however, from 2018 to 2022, the export prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was India ($X per ton), while Pakistan amounted to $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by India (X%).

Medicaments Containing Hormones Imports

Imports in Southern Asia

Medicaments containing hormones imports soared to X tons in 2022, with an increase of X% compared with 2021. Over the period under review, imports, however, showed a abrupt contraction. The most prominent rate of growth was recorded in 2020 when imports increased by X%. The volume of import peaked at X tons in 2014; however, from 2015 to 2022, imports remained at a lower figure.

In value terms, medicaments containing hormones imports skyrocketed to $X in 2022. In general, imports saw a moderate expansion. The level of import peaked at $X in 2014; however, from 2015 to 2022, imports failed to regain momentum.

Imports by Country

In 2022, Afghanistan (X tons) represented the major importer of medicaments containing hormones but not antibiotics, making up X% of total imports. India (X tons) ranks second in terms of the total imports with a X% share, followed by Pakistan (X%). Bangladesh (X tons) held a minor share of total imports.

From 2012 to 2022, average annual rates of growth with regard to medicaments containing hormones imports into Afghanistan stood at X%. At the same time, Bangladesh (X%), India (X%) and Pakistan (X%) displayed positive paces of growth. Moreover, Bangladesh emerged as the fastest-growing importer imported in Southern Asia, with a CAGR of X% from 2012-2022. While the share of India (X p.p.), Afghanistan (X p.p.), Pakistan (X p.p.) and Bangladesh (X p.p.) increased significantly, the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, India ($X) constitutes the largest market for imported medicaments containing hormones but not antibiotics in Southern Asia, comprising X% of total imports. The second position in the ranking was held by Afghanistan ($X), with a X% share of total imports. It was followed by Pakistan, with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value in India totaled X%. In the other countries, the average annual rates were as follows: Afghanistan (X% per year) and Pakistan (X% per year).

Import Prices by Country

In 2022, the import price in Southern Asia amounted to $X per ton, surging by X% against the previous year. In general, the import price showed buoyant growth. As a result, import price attained the peak level and is likely to continue growth in the immediate term.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was India ($X per ton), while Afghanistan ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Afghanistan (X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :